If a patient poses a question about an off-label use of a product on a public online forum, it is OK for the product’s manufacturer to respond, but it should do so privately, and not within view of a broader online audience, FDA says.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?